P. Yu. Filiniuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
P. Yu. Filiniuk has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alexander N. Shishkin
Saint Petersburg State University
2 shared publications - I. Yu. Panina
Pavlov University
2 shared publications - Ivan Yu. Pchelin
Saint Petersburg State University
2 shared publications - Natalia Khudyakova
St Petersburg State University
2 shared publications - Viktoriya Aleksandrovna Volovnikova
Санкт-Петербургский государственный университет
2 shared publications П. Ю. Филинюк
Санкт-Петербургский государственный университет
2 shared publications
Latest Publications
- Open Access
- 30 April 2024
- Published by Scientia Publishing House LTD in Juvenis scientia
- Vol. 10 (2) , 5-14
The Association Between Obesity Phenotypes and Cardiovascular Diseases
Cardiovascular diseases and obesity are related medical and social problems. However, some obese people remain free of cardiovascular disease for long periods of time, and the concept of obesity phenotypes that differ in cardiovascular risk has been actively studied. Currently, there are no generally accepted diagnostic criteria for them, and the mechanisms underlying their formation remain unclear. The purpose of this article is to discuss the literature data on obesity phenotypes, their relationship with cardiovascular diseases and mortality, as well as the place of obesity in the domestic algorithm for diagnosing stable coronary heart disease.
- 30 April 2024
- Published by Scientia Publishing House LTD in Juvenis scientia
- Vol. 10 (2) , 5-14
Open AccessThe Association Between Obesity Phenotypes and Cardiovascular Diseases
Cardiovascular diseases and obesity are related medical and social problems. However, some obese people remain free of cardiovascular disease for long periods of time, and the concept of obesity phenotypes that differ in cardiovascular risk has been actively studied. Currently, there are no generally accepted diagnostic criteria for them, and the mechanisms underlying their formation remain unclear. The purpose of this article is to discuss the literature data on obesity phenotypes, their relationship with cardiovascular diseases and mortality, as well as the place of obesity in the domestic algorithm for diagnosing stable coronary heart disease.
- Open Access
- 30 December 2023
- Published by Scientia Publishing House LTD in Juvenis scientia
- Vol. 9 (6) , 6-17
Some Features of Correction of Adipose Tissue Dysfunction
The rapid spread of obesity and associated cardiovascular disease is of serious concern in the scientific and medical field. Despite diverse approaches to solving these problems, there is still no visible success in the fight against obesity at the population level, and cardiovascular pathology still remains one of the main causes of death and disability in the world. This leads to attempts aimed at finding new therapeutic options. Targeted pharmacological therapy for adipose tissue dysfunction represents one of the potential solutions. In the present article, we review the effects of adipocytokines such as adiponectin and leptin, as one of the most well-studied markers of disruption of the normal functioning of adipose tissue, as well as some modern approaches to pharmacological correction of their effects on the cardiovascular system. The analysis of the data shows that hypoadiponectinemia and hyperleptinemia in combination with leptin resistance are associated with cardiovascular disease and poor prognosis, and correction of pathologically altered levels of the above-mentioned adipocytokines to achieve their optimal ratio may represent a relevant therapeutic goal.
- 30 December 2023
- Published by Scientia Publishing House LTD in Juvenis scientia
- Vol. 9 (6) , 6-17
Open AccessSome Features of Correction of Adipose Tissue Dysfunction
The rapid spread of obesity and associated cardiovascular disease is of serious concern in the scientific and medical field. Despite diverse approaches to solving these problems, there is still no visible success in the fight against obesity at the population level, and cardiovascular pathology still remains one of the main causes of death and disability in the world. This leads to attempts aimed at finding new therapeutic options. Targeted pharmacological therapy for adipose tissue dysfunction represents one of the potential solutions. In the present article, we review the effects of adipocytokines such as adiponectin and leptin, as one of the most well-studied markers of disruption of the normal functioning of adipose tissue, as well as some modern approaches to pharmacological correction of their effects on the cardiovascular system. The analysis of the data shows that hypoadiponectinemia and hyperleptinemia in combination with leptin resistance are associated with cardiovascular disease and poor prognosis, and correction of pathologically altered levels of the above-mentioned adipocytokines to achieve their optimal ratio may represent a relevant therapeutic goal.
- 23 June 2022
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 26 (2) , 77-84
SARCOPENIC OBESITY IN PATIENTS RECEIVING TREATMENT WITH PROGRAMMED HEMODIALYSIS
САРКОПЕНИЧЕСКОЕ ОЖИРЕНИЕ У БОЛЬНЫХ, ПОЛУЧАЮЩИХ ЛЕЧЕНИЕ ПРОГРАММНЫМ ГЕМОДИАЛИЗОМ
- 23 June 2022
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 26 (2) , 77-84
SARCOPENIC OBESITY IN PATIENTS RECEIVING TREATMENT WITH PROGRAMMED HEMODIALYSIS
САРКОПЕНИЧЕСКОЕ ОЖИРЕНИЕ У БОЛЬНЫХ, ПОЛУЧАЮЩИХ ЛЕЧЕНИЕ ПРОГРАММНЫМ ГЕМОДИАЛИЗОМ
- 13 February 2021
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 25 (2) , 66-72
Obesity diagnostics in patients with hemodialysis: bioimpedansometry and caliperometry
Obesity is considered one of the most common syndromes in medical practice. Over the past 40 years, the average body mass index (BMI) has increased by 10.3 % in men and by 9.4 % in women. It is believed that obesity, diagnosed by BMI, is a significant risk factor for the development of cardiovascular diseases, and, accordingly, negatively affects a person's life expectancy. Among the methods that make it possible not only to characterize the ratio of height and body weight but to give an idea of the amount of body fat, the most popular in our country are caliperometry and bioimpedance measurement. THE AIM: to assess the possibility of interchangeability of caliperometry and bioimpedance measurement in determining body fat mass in dialysis patients.PATIENTS AND METHODS. The study involved 140 patients, including 66 men and 58 women, receiving HD treatment. In general, the surveyed group can be characterized as clinically stable. To determine the body composition, all patients underwent caliperometry using the TVES KETS 100 electronic caliper.RESULTS. Fat mass according to caliperometry data was 40.0 % in women, 30.0 % in men, p = 0.0001. According to bioimpedance measurements – 39.9 and 28.3 %, respectively, p = 0.0001. During the ROC analysis, the area under the curve for caliperometry was 0.851 (CI 0.729-0.932), for bioimpedance measurements 0.839 (CI 0.715-0.932). The correlation between the two methods in determining body fat mass in kg was Rs = 0.991 p = 0.0001, and in % Rs = 0.985 p = 0.0001. When comparing the results of determining body fat by the Bland-Altman method, the average difference between the two methods was 0.6 ± 2.3 %, the degree of discrepancy was from -4 to + 5 %. The prevalence of obesity among dialysis patients by BMI was 29.4 % among women and 19.4 % among men. However, according to the results of both caliperometry and bioimpedance measurements, the real prevalence of obesity exceeded 90 %.CONCLUSION. Diagnosing obesity by BMI does not provide an indication of the true prevalence of obesity in dialysis patients. For this purpose, it is necessary to use bioimpedance or caliperometry. Both methods give comparable results and can be considered interchangeable.
- 13 February 2021
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 25 (2) , 66-72
Obesity diagnostics in patients with hemodialysis: bioimpedansometry and caliperometry
Obesity is considered one of the most common syndromes in medical practice. Over the past 40 years, the average body mass index (BMI) has increased by 10.3 % in men and by 9.4 % in women. It is believed that obesity, diagnosed by BMI, is a significant risk factor for the development of cardiovascular diseases, and, accordingly, negatively affects a person's life expectancy. Among the methods that make it possible not only to characterize the ratio of height and body weight but to give an idea of the amount of body fat, the most popular in our country are caliperometry and bioimpedance measurement. THE AIM: to assess the possibility of interchangeability of caliperometry and bioimpedance measurement in determining body fat mass in dialysis patients.PATIENTS AND METHODS. The study involved 140 patients, including 66 men and 58 women, receiving HD treatment. In general, the surveyed group can be characterized as clinically stable. To determine the body composition, all patients underwent caliperometry using the TVES KETS 100 electronic caliper.RESULTS. Fat mass according to caliperometry data was 40.0 % in women, 30.0 % in men, p = 0.0001. According to bioimpedance measurements – 39.9 and 28.3 %, respectively, p = 0.0001. During the ROC analysis, the area under the curve for caliperometry was 0.851 (CI 0.729-0.932), for bioimpedance measurements 0.839 (CI 0.715-0.932). The correlation between the two methods in determining body fat mass in kg was Rs = 0.991 p = 0.0001, and in % Rs = 0.985 p = 0.0001. When comparing the results of determining body fat by the Bland-Altman method, the average difference between the two methods was 0.6 ± 2.3 %, the degree of discrepancy was from -4 to + 5 %. The prevalence of obesity among dialysis patients by BMI was 29.4 % among women and 19.4 % among men. However, according to the results of both caliperometry and bioimpedance measurements, the real prevalence of obesity exceeded 90 %.CONCLUSION. Diagnosing obesity by BMI does not provide an indication of the true prevalence of obesity in dialysis patients. For this purpose, it is necessary to use bioimpedance or caliperometry. Both methods give comparable results and can be considered interchangeable.
- 25 January 2020
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 24 (1) , 51-59
Screening of insulin resistance in patients with hemodialysis
Insulin resistance (IR) is defined as a violation of the biological response to stimulation of the heart, skeletal muscle, liver, and adipose tissue. The reasons for the formation of the syndrome are diverse, and clinical diagnosis is difficult since there is no generally accepted test available to determine it. For the diagnosis of IR directly and indirectly developed test groups. The complexity of their implementation in some cohorts of patients led to the development of a number of glycemic indices. However, no consensus has yet been reached on which one should be preferred. THE AIM: to compare IR screening methods in a cohort of hemodialysis patients. PATIENTS AND METHODS. 124 patients were examined, including 66 men and 58 women aged 57.6 ± 13.6 years, receiving HD treatment for 75.4 ± 44.5 months. For the screening of IR, the HOMA-1 and HOMA-2 glucose homeostasis model, QUICKI index, and triglycerides/glucose (TriH) were used. RESULTS. When conducting a nonparametric correlation analysis for fasting insulin plasma concentrations, statistically significant relationships were revealed only in men: with BMI (Rs = 0.258 p = 0.049), waist circumference to height ratio (Rs = 0.316 p = 0.015), and amount of dietary protein (Rs = 0.271 p = 0.039), systolic blood pressure (Rs = 0.308 p = 0.018), diastolic blood pressure (Rs = 0.290 p = 0.027), C-reactive protein level (Rs = 0.579 p = 0.0001). In women, no statistically significant correlations were found. The value of the Charlson index, as well as tobacco smoking, currently or in the history of the indicators of insulin resistance had no effect. According to the results of logistic regression analysis, the risk of developing clinical manifestations of atherosclerotic lesions of any vascular pool increased by 4.5 times (χ2 = 4.582 p = 0.032) with IR in the HOMA-1 model of more than 2.7 units, however, only in men. The relationship of other indicators of IR with atherosclerosis was not identified. CONCLUSION. A comparison of surrogate models of IR, from our point of view, allows us to distinguish HOMA-1 and HOMA-2. Probably, for the cross-sectional studies it is advisable to use the first of them, and for longitudinal – the second.
- 25 January 2020
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 24 (1) , 51-59
Screening of insulin resistance in patients with hemodialysis
Insulin resistance (IR) is defined as a violation of the biological response to stimulation of the heart, skeletal muscle, liver, and adipose tissue. The reasons for the formation of the syndrome are diverse, and clinical diagnosis is difficult since there is no generally accepted test available to determine it. For the diagnosis of IR directly and indirectly developed test groups. The complexity of their implementation in some cohorts of patients led to the development of a number of glycemic indices. However, no consensus has yet been reached on which one should be preferred. THE AIM: to compare IR screening methods in a cohort of hemodialysis patients. PATIENTS AND METHODS. 124 patients were examined, including 66 men and 58 women aged 57.6 ± 13.6 years, receiving HD treatment for 75.4 ± 44.5 months. For the screening of IR, the HOMA-1 and HOMA-2 glucose homeostasis model, QUICKI index, and triglycerides/glucose (TriH) were used. RESULTS. When conducting a nonparametric correlation analysis for fasting insulin plasma concentrations, statistically significant relationships were revealed only in men: with BMI (Rs = 0.258 p = 0.049), waist circumference to height ratio (Rs = 0.316 p = 0.015), and amount of dietary protein (Rs = 0.271 p = 0.039), systolic blood pressure (Rs = 0.308 p = 0.018), diastolic blood pressure (Rs = 0.290 p = 0.027), C-reactive protein level (Rs = 0.579 p = 0.0001). In women, no statistically significant correlations were found. The value of the Charlson index, as well as tobacco smoking, currently or in the history of the indicators of insulin resistance had no effect. According to the results of logistic regression analysis, the risk of developing clinical manifestations of atherosclerotic lesions of any vascular pool increased by 4.5 times (χ2 = 4.582 p = 0.032) with IR in the HOMA-1 model of more than 2.7 units, however, only in men. The relationship of other indicators of IR with atherosclerosis was not identified. CONCLUSION. A comparison of surrogate models of IR, from our point of view, allows us to distinguish HOMA-1 and HOMA-2. Probably, for the cross-sectional studies it is advisable to use the first of them, and for longitudinal – the second.